动物保健市场——按产品[药品、医疗器械、服务]、按动物、分销——到 2032 年的全球预测
市场调查报告书
商品编码
1260669

动物保健市场——按产品[药品、医疗器械、服务]、按动物、分销——到 2032 年的全球预测

Animal Healthcare Market - By Product [Pharmaceuticals, Medical Device, Service], Animal, Distribution - Global Forecast to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 306 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于动物福利和宠物健康方面的支出增加,预计到 2032 年动物保健市场将呈指数级增长。

此外,宠物美容、锻炼、散步、训练、寄宿、宠物看护和庭院工作等宠物服务支出的增加预计也将在扩大市场方面发挥重要作用。 此外,对兽药预防疾病和提供优质护理的需求不断增长,也将加速市场扩张。

随着新兴经济体难以维持基本的人力资源、财务和实施计划,预计未来几年行业增长将停滞不前。 此外,动物保健是一个被忽视的领域,这可能会对未来的市场前景产生不利影响。 然而,人们对人畜共患疾病的认识不断提高,以及支持在线药店的电子商务平台的出现,将进一步推动未来几年的市场增长。

总体而言,动物保健市场按产品、动物、分销渠道和地区进行细分。

按产品划分,由于对兽医服务的需求不断增长,预计到 2022 年兽医保健服务的市场份额将超过 755 亿美元,并且到 2032 年将显着增长。 此外,发达国家日益增加的动物健康问题和生活方式的改变将进一步增加对兽医医疗服务的偏好,这将推动业务增长。

按动物分类,由于宠物拥有量增加、兽药支出增加以及对优质宠物产品的需求增加,预计到 2032 年底伴侣动物市场将出现显着增长。 此外,移动宠物美容服务、宠物和宠物保险等医疗保健设施创新的增加,也将在预测期内支持该细分市场的增长。

由于动物护理产品种类繁多且价格相对较低,预计经销商将呈指数级增长。 而且代理服务的客户数量多,所以是双赢的。 商家可以利用规模经济,客户也可以享受折扣价。 批发价格和种类繁多的产品有望在未来促进该细分市场的扩张。

按地区划分,预计 2022 年北美动物保健市场的收入份额将超过 39%,在预测期内呈现显着增长。 该地区的市场扩张归因于可支配收入增加推动宠物健康支出增加,以及针对易患慢性病的牲畜和伴侣动物的个性化宠物护理的进步。这是有可能的。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章动物保健行业洞察

  • 按行业细分
  • 行业格局,2018-2032 年版
  • 行业影响因子
    • 司机
      • 增加宠物的陪伴
      • 加强政府和公共机构对动物福利的支持
      • 对动物在线药店的需求不断扩大
      • 动物保健费用增加
    • 行业潜在的风险和挑战
      • 与动物保健药物相关的高成本
      • 新兴国家/地区在宠物保健方面的支出较低
  • 增长分析
    • 按产品分类
    • 按动物类型
    • 按分销渠道
  • COVID-19 影响分析
  • 监管状况
    • 美国
    • 欧洲
    • 亚太地区
  • 技术概况
  • 退款场景
  • 动物保健行业的风险资本家场景
  • 政策和情况
  • 差距分析
  • 消费者行为趋势
  • 行业生态系统
  • 波特分析
  • 2021 年竞争格局
    • 2021 年公司矩阵分析
  • PESTEL 分析

第 4 章竞争格局,2021 年

  • 介绍
  • 2021 年公司矩阵分析
  • 战略仪表板,2021 年

第 5 章动物保健市场:按产品分类

  • 主要细分趋势
  • 医药
    • 药物
      • 抗瘫剂
      • 抗炎作用
      • 抗感染药
      • 其他
    • 疫苗
      • 改良活疫苗 (MLV)
      • 灭活□□疫苗
      • 其他
    • 药用饲料添加剂
      • 抗生素
      • 维生素
      • 抗氧化剂
      • 益生元和益生菌
      • 矿物质
      • 其他
  • 医疗设备
    • 兽医诊断设备
    • 兽医麻醉设备
    • 动物监测设备
    • 兽医手术器械
    • 动物消耗品
    • 其他
  • 兽医服务
  • 医疗设备
  • 兽医服务

第 6 章动物保健市场:动物类型

  • 主要细分趋势
  • 家畜
    • 家禽
    • 斯温
    • 奶牛
    • 其他
  • 伴侣动物
    • 马肉
    • 其他

第 7 章动物保健品市场:按分销渠道

  • 主要细分趋势
  • 药店
  • 电子商务
  • 分销商

第 8 章动物保健市场:区域细分

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 波兰
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 台湾
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 海湾合作委员会国家
    • 以色列

第九章公司简介

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Merck & Co
  • Symrise
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
  • Medtronic plc
  • IDEXX Laboratories
  • HIPRA
  • Endovac Animal Health
  • B. Braun Vet Care(B Braun Melsungen AG)
  • Sklar Surgical Instruments
  • Neogen Corporation
简介目录
Product Code: 735

Animal Healthcare Market is slated to grow exponentially through 2032, owing to the rising expenditure on animal welfare and pet health. Furthermore, increasing spending on pet services such as grooming, exercise, walking, training, boarding, pet sitting, and yard service will also play a key role in market expansion. In addition, the growing need for animal medicines to prevent diseases and offer quality treatment to animals is further slated to escalate the market progression.

The industry is anticipated to witness stagnant growth in the coming years, as developing countries struggle to maintain basic human facilities, raise funds, and organize several programs. Besides, animal healthcare is a neglected sector, which may also negatively influence the market outlook in the future. However, the increasing awareness regarding zoonotic illnesses and the mounting presence of e-commerce platforms supporting online pharmacies will further drive market growth in the coming years.

Overall, the animal healthcare market is segmented in terms of product, animal, distribution channel, and region.

Considering the product, the veterinary services segment held over USD 75.5 billion market share in 2022 and is anticipated to grow considerably through 2032, owing to the rising demand for veterinary services. In addition, the increasing prevalence of health issues in animals and changing lifestyles in developed countries will further increase the preference for veterinary services, thereby boosting business growth.

Based on animals, the companion animal segment is slated to witness massive growth by 2032 end, owing to the increasing adoption of pets, rising expenditure on veterinary care, and growing demand for premium pet products. Besides, ongoing innovations in medical facilities for mobile pet grooming services, pets, and pet insurance will support the segmental growth over the forecast period.

By distribution channel, the distributors segment is slated to grow exponentially owing to the availability of a wide variety of animal care products and comparatively lower pricing. Besides, distributors serve large groups of customers, which is advantageous for both parties. It allows the distributor to use economies of scale, while the customer receives the goods at a discounted price. Wholesale pricing and presence of wide variety of product alternatives are further slated to drive segmental expansion in the future.

Regionally, the North America animal healthcare market held over 39% revenue share in 2022 and is likely to demonstrate massive growth during the forecast period. The regional market expansion can be attributed to the increased expenditure in pet health empowered by high disposable income and advancements in personalized pet medicine for livestock & companion animals that are susceptible to chronic illness.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data animal types
    • 1.6.1 Secondary
      • 1.6.1.1 Paid animal types
      • 1.6.1.2 Unpaid animal types
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Animal healthcare industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Animal type trends
    • 2.1.4 Distribution channel trends
    • 2.1.5 Regional trends

Chapter 3 Animal Healthcare Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing pet adoption for companionship
      • 3.3.1.2 Increasing support offered by government and public organizations for animal care
      • 3.3.1.3 Growing demand for online veterinary pharmacies
      • 3.3.1.4 Increase in animal healthcare expenditure
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost associated with animal healthcare drugs
      • 3.3.2.2 Low out of pocket expenditure on pet healthcare in developing countries
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By animal type
    • 3.4.3 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
  • 3.7 Technology landscape
  • 3.8 Reimbursement scenario
  • 3.9 Venture capitalist scenario in the animal healthcare industry
  • 3.10 Policy landscape
  • 3.11 Gap analysis
  • 3.12 Consumer behaviour trends
  • 3.13 Industry ecosystem
  • 3.14 Porter's analysis
    • 3.14.1 Industry rivalry
    • 3.14.2 Bargaining power of suppliers
    • 3.14.3 Bargaining power of buyers
    • 3.14.4 Threat of substitute
    • 3.14.5 Threat of new entrants
  • 3.15 Competitive landscape, 2021
    • 3.15.1 Company matrix analysis, 2021
  • 3.16 PESTEL analysis
    • 3.16.1 Political
    • 3.16.2 Economical
    • 3.16.3 Social
    • 3.16.4 Technological
    • 3.16.5 Legal
    • 3.16.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Animal Healthcare Market, By Product

  • 5.1 Key segment trends
  • 5.2 Pharmaceuticals
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.2.2 Drugs
      • 5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.2 Antiparisitic
        • 5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.3 Anti-inflammatory
        • 5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.4 Anti-infectives
        • 5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.5 Others
        • 5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.2.3 Vaccines
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Modified Live Vaccines (MLV)
        • 5.2.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.3 Killed Inactivated Vaccines
        • 5.2.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.4 Others
        • 5.2.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Medicated Feed Additives
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Antibiotics
        • 5.2.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.3 Vitamins
        • 5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.4 Enzymes
        • 5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.5 Antioxidants
        • 5.2.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.6 Prebiotics and probiotics
        • 5.2.4.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.7 Minerals
        • 5.2.4.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.8 Others
        • 5.2.4.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Medical devices
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Veterinary Diagnostic Equipment
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Veterinary Anesthesia Equipment
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Veterinary Animal type Monitoring Equipment
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Veterinary Surgical Equipment
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.6 Veterinary Consumables
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.7 Others
      • 5.3.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Veterinary services
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Medical devices
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.6 Veterinary services
    • 5.6.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Animal Healthcare Market, By Animal type

  • 6.1 Key segment trends
  • 6.2 Livestock animals
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.2 Poultry
      • 6.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.3 Swine
      • 6.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.4 Cattle
      • 6.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.5 Fish
      • 6.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.6 Others
      • 6.2.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Companion animals
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.2 Dogs
      • 6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.3 Cats
      • 6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.4 Horses
      • 6.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.5 Others
      • 6.3.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Animal Healthcare Market, By Distribution Channel

  • 7.1 Key segment trends
  • 7.2 Pharmacies
    • 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.3 E-commerce
    • 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.4 Distributors
    • 7.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Animal Healthcare Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Poland
    • 8.3.7 The Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Taiwan
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 GCC Countries
    • 8.6.3 Israel

Chapter 9 Company Profiles

  • 9.1 Boehringer Ingelheim International GmbH
  • 9.2 Ceva Sante Animale
  • 9.3 Dechra Pharmaceuticals
  • 9.4 Elanco Animal Health
  • 9.5 Merck & Co
  • 9.6 Symrise
  • 9.7 Vetoquinol SA
  • 9.8 Virbac SA
  • 9.9 Zoetis, Inc.
  • 9.10 Medtronic plc
  • 9.11 IDEXX Laboratories
  • 9.12 HIPRA
  • 9.13 Endovac Animal Health
  • 9.14 B. Braun Vet Care (B Braun Melsungen AG)
  • 9.15 Sklar Surgical Instruments
  • 9.16 Neogen Corporation